e-Library : Press ReleasesRss
23 Apr 2013
EFPIA and EuropaBio welcome European Commission Consensus Information Document on biosimilars in the European pharmaceutical environment
19 Apr 2013
Brussels, 19 April 2013
18 Apr 2013
17 Apr 2013
European Stakeholder Model partners move forward with implementation of the European Medicines Verification System
16 Apr 2013
INTERPOL and pharmaceutical industry join forces in new global initiative to protect patients from counterfeit medicines
12 Mar 2013
28 Feb 2013
Today is rare disease day. These are diseases we do not often talk about and they do not get the attention that other diseases do. These are often genetic, chronic and serious diseases and they affect a serious amount of people.
13 Feb 2013
11 Feb 2013
Brussels, 11 February 2013 -Today the Innovative Medicines Initiative (link) will launch two new projects through its antimicrobial resistance programme New Drugs for Bad Bugs (ND4BB).
6 Feb 2013
Healthcare Coalition on Data Protection calls for EU Data Protection Regulation to recognise the essential role of personal data in healthcare
29 Jan 2013
Brussels– 29 January 2013 - Today the Healthcare Coalition on Data Protection published a joint statement highlighting the role of personal data in delivering high quality, patient-centred healthcare and conducting effective clini
EDCTP and EFPIA sign memorandum of understanding on a Clinical Research Fellowship Scheme for sub-Saharan Africa
24 Jan 2013
23 Jan 2013
Tags: Clinical trials, Development of Medicines, Global health, Press Releases, Research & Innovation
Brussels, 23 January 2013: Yesterday, the MEP Christofer Fjellner (Sweden, EPP) and EFPIA hosted a panel discussion to discuss healthcare technology transfer to third countries.
22 Nov 2012
Tags: Clinical trials, Data privacy, Development of Medicines, Press Releases, Responsible Industry, Transparency
London, 22 November 2012: Today’s workshop gave a constructive insight into the different views on the sensitive issue of clinical data transparency. It is impossible to ignore these differences.
14 Nov 2012
Tags: Clinical trials, Development of Medicines, Press Releases, Research, Responsible Industry, Transparency
Brussels, 14 November 2012: Richard Bergström, speaking today, said:
13 Nov 2012
High-Level EDCTP Conference: African and European policy-makers and EFPIA discuss the EDCTP-II program
6 Nov 2012
06.11.2012, Brussels: EFPIA is delighted to announce the designation of Christopher A. Viehbacher, Chief Executive Officer of Sanofi as the new President elect of EFPIA.
16 Oct 2012
Brussels, 16 Ocotober 2012: EFPIA is committed to building trust in how the pharmaceutical industry conducts its business and interacts with key stakeholders.
EFPIA welcomes Commission decision for a policy strategy agenda to strengthen the competitiveness of the pharmaceutical industry
11 Oct 2012
Tags: Development of Medicines, Innovation, Medicines Development, Patient, Patients’ Access to Medicines, Press Releases, Pricing, Research, Research & Innovation, Trade competitiveness
Need for concrete measures at national level to help stimulate innovation and ensure access for all European patients to modern medicines
9 Oct 2012
Tags: IMI, Innovation, Patient, Patients’ Access to Medicines, Press Releases, Research, Research & Innovation
11.10.2012, Brussels: EFPIA would like to congratulate Sir John Gurdon and Shinya Yamanaka for winning this year’s Nobel Prize of medicine for their work on the reprogramming of adult cells back into embryo-like stem cells that ca
8 Oct 2012
Tags: Access, Anti-Counterfeiting, Development of Medicines, ESM, Falsified medicines, Patients’ Access to Medicines, Press Releases
11.10.2012, Brussels: Interpol last week announced the seizure of over 3.75million units of counterfeit medicines worth over 10million USD.
5 Oct 2012
Tags: Global health, Intellectual Property, Patient, Patients’ Access to Medicines, Press Releases, Pricing
On Tuesday 2nd October MSF launched an online resource to help civil society groups and patient groups in developing countries to challenge unwarranted drug patents through patent oppositions.
Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world
24 Jul 2012
17 Jul 2012
Tags: Clinical trials, Innovation, Patient, Press Releases, Regulation, Research, Research & Innovation, Safety
EFPIA welcomes the proposal for a new Regulation on Clinical Trials on Medicinal Products for Human Use adopted today by the European Commission as a first step towards further cooperation in the clinical trials assessment process across the EU.
27 Jun 2012
Europe must make choices to remain a home for biomedical innovation.
EU Pharmaceutical industry leaders call for revision of German model for assessment of new medicines
8 Jun 2012
Berlin, 8 June, 2012: In today's meeting in Berlin the leading pharmaceutical companies of Europe, represented in EFPIA, asked the German Government for urgent action to protect patient access to new medicines and ensure that Germany remains a home... more
World Anti-Counterfeiting Day 2012: ESM Progress in seeking to protect European Patients from Counterfeit Medicines
7 Jun 2012
On the occasion of World Anti-Counterfeiting Day, EAEPC, EFPIA, GIRP and PGEU are pleased to announce significant progress on their proposed European Stakeholder Model (ESM), a European medicines verification project aimed at preventing falsified... more
24 May 2012
EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the launch today by the Innovative Medicines Initiative (IMI) public-private partnership, a €223,7 million programme to tackle antimicrobial resistance and to speed... more
EFPIA Board Moves to Next Phase in Setting Up a Cost-Effective System For Medicines Verification with Stakeholders
2 May 2012
EFPIA, the voice of the research-based pharmaceutical industry in Europe, is pleased to announce that on 27 April 2012 its Board formally adopted a Memorandum of Understanding (MoU) on medicines verification developed jointly with key supply chain... more
11 Apr 2012
The European Federation of Pharmaceutical Industries and Associations (EFPIA) is pleased to announce the official launch of the tendering process for key components of its European Medicines Verification System (EMVS) as of 5th April 2012.
27 Mar 2012
Today, the European Medicines Agency released a guidance on increased transparency and access to information included in companies' applications for marketing authorisation. EFPIA, the voice of the research-based pharmaceutical industry, welcomes... more
Best Initiative of the Year in Pharmacy awarded to EFPIA-GIRP-PGEU for their core principles on European medicines verification
16 Mar 2012
Representatives from three European associations (EFPIA, GIRP and PGEU) were in Madrid, Spain last Monday, to receive awards for the “2011 Best Pharmacy Initiatives of the Year”. The awards are given out by the Spanish newspaper Correo Farmaceutico... more
1 Mar 2012
Europe’s pharmaceutical industry welcomes the Commission proposal for a revised Transparency Directive but calls on European Institutions to set up the debate on solidarity among Member States on pharmaceuticals.
26 Jan 2012
At the occasion of a workshop organized today in Strasbourg by the European Directorate for the Quality of Medicines & Healthcare (EDQM) to present its “eTact” coding system, EAEPC, EFPIA, GIRP and PGEU would like to welcome EDQM’s involvement... more
8 Dec 2011
The Healthcare Industry is pleased to present today in the setting of the EUnetHTA Joint Action Conference in Gdansk, a jointly developed position paper on ‘The value of industry involvement in HTA’. The paper outlines the industry contribution to... more
6 Dec 2011
EFPIA, the voice of the research-based pharmaceutical industry in Europe, supports the idea to establish a “European Council for Health Research”, launched last week by the Alliance for Biomedical Research in Europe representing 16 leading European... more
30 Nov 2011
EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the launch today of the European Commission’s new Framework for Research and Innovation: Horizon 2020.
17 Nov 2011
EFPIA, the voice of the research-based pharmaceutical industry in Europe, welcomes the publication today of the European Commission’s “Strategy and Action Plan to Tackle the Threat of Antibiotic Resistance”.